Fruquintinib Combined With mFOLFOX6/FOLFIRI in First-line Treatment for Metastatic Colorectal Cancer
Clinical trial NCT05004441 · UNKNOWN
Trial details
- NCT number
- NCT05004441
- Sponsor
- Zhou Fuxiang
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-22
- Primary completion
- 2022-12-30
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.